What Else Analysts Want To Know About Phase III Data For TMC’s Inclisiran

 
• By Joseph Haas
  
LDL (Bad) Cholesterol level chart on a table. - Image
TMC hopes inclisiran can reduce LDL-C levels with twice-annual dosing

More from Clinical Trials

More from R&D